Abstract
Introduction Cytogenetic abnormalities have a significant prognostic effect in many hematologic neoplasms. Monosomal karyotype (MK), a newly recognized cytogenetic category, has been reported to be a marker of poor prognosis in patients with myelodysplastic syndromes and myelofibrosis, but its effect in chronic myelomonocytic leukemia (CMML) remains relatively unknown. Patients and Methods A retrospective study of cases diagnosed with CMML found a total of 262 patients. Patient characteristics, cytogenetic data, and survival were analyzed. Results Cytogenetic analysis found diploidy in 167 patients (64%). Trisomy 8 was the most frequent cytogenetic abnormality at 8% (22), followed by complex karyotype (CK) at 5% (14), -7 at 4% (10), and MK at 3% (7, of which 6 [86%] were also CK). Median overall survival was statistically significantly worse in MK-positive cases than in MK-negative cases (MK+ vs. MK-). Patients with MK+ only or CK+MK+ did worse than any other group. Conclusion MK is a rare entity but can predict statistically significantly shorter overall survival among all other cytogenetic categories.
Original language | English (US) |
---|---|
Pages (from-to) | e39-e41 |
Journal | Clinical Lymphoma, Myeloma and Leukemia |
Volume | 15 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1 2015 |
Keywords
- CMML
- Cytogenetic analysis
- MK
- Prognosis
- Survival
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research